Credit – CDC COCA
# 6179
Primarily of interest to clinicians - including physicians, nurses, physician’s assistants, pharmacists, paramedics, veterinarians, epidemiologists, public health practitioners, and state and local health department officials - the CDC will hold a webinar later today on the use of antiviral medications for influenza.
These COCA (Clinician Outreach Communication Activity) calls are designed to ensure that clinicians have the up-to-date information for their practices, and also provide Continuing Education Credits.
The details of today’s COCA call follows, along with links to some recent calls that are archived and available for viewing.
2011-2012 Influenza Season: Antiviral Medication Recommendations
= Continuing Education Credits
Date: Tuesday, February 28, 2012
Time: 2:00 - 3:00 pm (Eastern Time)
Participate by Phone:
Dial:800-779-7163
Passcode: 7319016Participate by Webinar:
https://www.mymeetings.com/nc/join.php?i=PW6062720&p=7319016&t=c
Presenter(s):
Timothy Uyeki, MD, MPH, MPP
CAPT, U.S. Public Health Service
Deputy Chief for Science
Epidemiology and Prevention Branch
Influenza Division
National Center for Immunization and Respiratory Diseases
CDCOverview:
CDC estimates that influenza virus infections in the United States result in an average of more than 200,000 related hospitalizations, and between 3,300 to 49,000 deaths each year, depending upon the severity of the influenza season. Annual influenza vaccination is recommended for all persons aged 6 months and older, and is the best way to prevent influenza. However, available evidence consistently indicates that antiviral treatment, when initiated as early as possible in patients with confirmed or suspected influenza, can reduce severe outcomes of influenza. During this COCA conference call, a subject matter expert will review current Advisory Committee on Immunization Practices (ACIP) and CDC guidance on the use of antiviral medications in the prevention and treatment of influenza.
For a list of recent (and upcoming) conference calls, visit this link.
